Literature DB >> 23172766

Outcome of infants with prenatally diagnosed congenital heart disease delivered outside specialist paediatric cardiac centres.

Katherine Anagnostou1, Lisa Messenger, Robert Yates, Wilf Kelsall.   

Abstract

OBJECTIVE: To determine the outcome of neonates with a suspected antenatal diagnosis of congenital heart disease (CHD) who were delivered away from a paediatric cardiothoracic centre and were initially managed in a level 3 Neonatal Intensive Care Unit.
METHODS: An 18-year ongoing study conducted in a single institution.
RESULTS: Between 1992 and 2009, 143 fetuses with suspected CHD were identified, and 124 babies were delivered locally. 13 babies with a normal postnatal echocardiogram and six with isolated arrhythmias were excluded from the study. Structural CHD was confirmed in 105 infants; of these, 94 (90%) survived the neonatal period. Of the 11 neonatal deaths, only four of these infants underwent surgery; most had additional risk factors including: prematurity, very low birth weight, and genetic and other structural congenital anomalies.
CONCLUSIONS: This study demonstrates that appropriately selected infants with antenatally diagnosed CHD can be safely delivered and initially managed in a non-cardiac centre during their neonatal period. Deliveries need to be carefully planned with close collaboration among neonatologists, obstetricians, paediatric cardiologists, mid-wives and parents.

Entities:  

Mesh:

Year:  2012        PMID: 23172766     DOI: 10.1136/archdischild-2011-300488

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  8 in total

1.  Transfer of Neonates with Critical Congenital Heart Disease Within a Regionalized Network.

Authors:  Michael F Swartz; Jill M Cholette; Jennifer M Orie; Marshall L Jacobs; Jeffrey P Jacobs; George M Alfieris
Journal:  Pediatr Cardiol       Date:  2017-07-15       Impact factor: 1.655

2.  Birth Location in Infants with Prenatally Diagnosed Hypoplastic Left Heart Syndrome.

Authors:  Mehul Patel; Sunkyung Yu; Jennifer C Romano; Katherine Bates; Karen Uzark; Kurt Schumacher; Sowmya Balasubramanian; Sarah Gelehrter
Journal:  Pediatr Cardiol       Date:  2021-10-19       Impact factor: 1.655

3.  Care Levels for Fetal Therapy Centers.

Authors:  Ahmet A Baschat; Sean B Blackwell; Debnath Chatterjee; James J Cummings; Stephen P Emery; Shinjiro Hirose; Lisa M Hollier; Anthony Johnson; Sarah J Kilpatrick; Francois I Luks; M Kathryn Menard; Lawrence B McCullough; Julie S Moldenhauer; Anita J Moon-Grady; George B Mychaliska; Michael Narvey; Mary E Norton; Mark D Rollins; Eric D Skarsgard; KuoJen Tsao; Barbara B Warner; Abigail Wilpers; Greg Ryan
Journal:  Obstet Gynecol       Date:  2022-05-02       Impact factor: 7.623

4.  Transport of infants with congenital heart disease: benefits of antenatal diagnosis.

Authors:  Neelam Gupta; Louise Leven; Michael Stewart; Michael Cheung; Neil Patel
Journal:  Eur J Pediatr       Date:  2013-12-11       Impact factor: 3.183

5.  Mode of delivery in pregnancies complicated by major fetal congenital heart disease: a retrospective cohort study.

Authors:  C A Walsh; A MacTiernan; S Farrell; C Mulcahy; C J McMahon; O Franklin; D Coleman; R Mahony; S Higgins; S Carroll; P McParland; F M McAuliffe
Journal:  J Perinatol       Date:  2014-05-29       Impact factor: 2.521

6.  Perinatal outcomes and congenital heart defect prognosis in 53313 non-selected perinatal infants.

Authors:  Donghua Xie; Hua Wang; Zhiyu Liu; Junqun Fang; Tubao Yang; Shujin Zhou; Aihua Wang; Jiabi Qin; Lili Xiong
Journal:  PLoS One       Date:  2017-06-07       Impact factor: 3.240

7.  The antenatal diagnosis of fetal anomaly: where to deliver the baby?

Authors:  Martin P Ward Platt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-12-13       Impact factor: 5.747

8.  Possible Prevention of Neonatal Death: A Regional Population-Based Study in Japan.

Authors:  Shigeki Koshida; Takahide Yanagi; Tetsuo Ono; Shunichiro Tsuji; Kentaro Takahashi
Journal:  Yonsei Med J       Date:  2016-03       Impact factor: 2.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.